211 related articles for article (PubMed ID: 12121792)
21. A new candidate for insulinomimetic vanadium complex: synergism of oxovanadium(IV)porphyrin and sodium ascorbate.
Sakurai H; Inohara T; Adachi Y; Kawabe K; Yasui H; Takada J
Bioorg Med Chem Lett; 2004 Mar; 14(5):1093-6. PubMed ID: 14980642
[TBL] [Abstract][Full Text] [Related]
22. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
23. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Willsky GR; Goldfine AB; Kostyniak PJ; McNeill JH; Yang LQ; Khan HR; Crans DC
J Inorg Biochem; 2001 May; 85(1):33-42. PubMed ID: 11377693
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, spectroscopic, structural and thermal characterizations of vanadyl(IV) adenine complex prospective as antidiabetic drug agent.
El-Megharbel SM; Hamza RZ; Refat MS
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():850-64. PubMed ID: 25150436
[TBL] [Abstract][Full Text] [Related]
25. The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes.
Yoshikawa Y; Ueda E; Kojima Y; Sakurai H
Life Sci; 2004 Jun; 75(6):741-51. PubMed ID: 15172182
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of insulin signaling pathway in adipocytes by oxovanadium(IV) complexes.
Basuki W; Hiromura M; Adachi Y; Tayama K; Hattori M; Sakurai H
Biochem Biophys Res Commun; 2006 Oct; 349(3):1163-70. PubMed ID: 16970914
[TBL] [Abstract][Full Text] [Related]
28. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic potential of vanadium in treating diabetes mellitus].
Sakurai H
Clin Calcium; 2005 Jan; 15(1):49-57. PubMed ID: 15632473
[TBL] [Abstract][Full Text] [Related]
30. Vanadyl-biguanide complexes as potential synergistic insulin mimics.
Woo LC; Yuen VG; Thompson KH; McNeill JH; Orvig C
J Inorg Biochem; 1999 Sep; 76(3-4):251-7. PubMed ID: 10605840
[TBL] [Abstract][Full Text] [Related]
31. Axial ligand coordination in sterically strained vanadyl porphyrins: synthesis, structure, and properties.
Ghosh SK; Patra R; Rath SP
Inorg Chem; 2008 Nov; 47(21):9848-56. PubMed ID: 18823111
[TBL] [Abstract][Full Text] [Related]
32. A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex.
Karmaker S; Saha TK; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2006 Sep; 100(9):1535-46. PubMed ID: 16824605
[TBL] [Abstract][Full Text] [Related]
33. Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
Amin SS; Cryer K; Zhang B; Dutta SK; Eaton SS; Anderson OP; Miller SM; Reul BA; Brichard SM; Crans DC
Inorg Chem; 2000 Feb; 39(3):406-16. PubMed ID: 11229556
[TBL] [Abstract][Full Text] [Related]
34. A new family of insulin-mimetic vanadium complexes derived from 5-carboalkoxypicolinates.
Gätjens J; Meier B; Kiss T; Nagy EM; Buglyó P; Sakurai H; Kawabe K; Rehder D
Chemistry; 2003 Oct; 9(20):4924-35. PubMed ID: 14562311
[TBL] [Abstract][Full Text] [Related]
35. [Synthesis and hypoglycemic activity of bis(L-malato)oxovanadium(IV)].
Gorodetskiĭ VK; Tochilkin AI; Beliaeva NF; Kovel'man IR; Korovkin BF
Biomed Khim; 2011; 57(1):133-7. PubMed ID: 21516785
[TBL] [Abstract][Full Text] [Related]
36. ESR characterization and metallokinetic analysis of Cr(V) in the blood of rats given carcinogen chromate(VI) compounds.
Sakurai H; Takechi K; Tsuboi H; Yasui H
J Inorg Biochem; 1999 Jul; 76(1):71-80. PubMed ID: 10530008
[TBL] [Abstract][Full Text] [Related]
37. Syntheses, structures, stability, and insulin-like activities of peroxovanadium(V) complexes with a heteroligand.
Kanamori K; Nishida K; Miyata N; Okamoto K; Miyoshi Y; Tamura A; Sakurai H
J Inorg Biochem; 2001 Oct; 86(4):649-56. PubMed ID: 11583782
[TBL] [Abstract][Full Text] [Related]
38. Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties.
Smee JJ; Epps JA; Ooms K; Bolte SE; Polenova T; Baruah B; Yang L; Ding W; Li M; Willsky GR; la Cour A; Anderson OP; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):575-84. PubMed ID: 19201030
[TBL] [Abstract][Full Text] [Related]
39. In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes.
Cam MC; Cros GH; Serrano JJ; Lazaro R; McNeill JH
Diabetes Res Clin Pract; 1993 May; 20(2):111-21. PubMed ID: 8375263
[TBL] [Abstract][Full Text] [Related]
40. Insulinomimetic Zn(II) complexes as evaluated by both glucose-uptake activity and inhibition of free fatty acids release in isolated rat adipocytes.
Nishide M; Yoshikawa Y; Yoshikawa EU; Matsumoto K; Sakurai H; Kajiwara NM
Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1181-3. PubMed ID: 18670123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]